Amylyx Pharmaceuticals, Inc. (AMLX)

14.51 +0.14 (+0.97%) USD  |  NASDAQ  |  Feb 26, 10:23
More

Amylyx Pharmaceuticals Total Expenses (% of Quarterly Revenues)

Total Expenses (% of Quarterly Revenues) Chart

View Total Expenses (% of Quarterly Revenues) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Quarterly Revenues) Benchmarks

View Total Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Cytokinetics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
MediciNova, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade